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https://doi.org/10.1016/j.stemcr.2018.01.020SUMMARYSelf-renewal and differentiation of adult stem cells are tightly regulated partly through configuration of chromatin structure by
chromatin remodelers. Using knockout mice, we here demonstrate that bromodomain PHD finger transcription factor (BPTF), a
component of the nucleosome remodeling factor (NURF) chromatin-remodeling complex, is essential for maintaining the population
size of hematopoietic stem/progenitor cells (HSPCs), including long-term hematopoietic stem cells (HSCs). Bptf-deficient HSCs are
defective in reconstituted hematopoiesis, and hematopoietic-specific knockout of Bptf caused profound defects including bone marrow
failure and anemia. Genome-wide transcriptome profiling revealed that BPTF loss caused downregulation of HSC-specific gene-
expression programs, which contain several master transcription factors (Meis1, Pbx1, Mn1, and Lmo2) required for HSC maintenance
and self-renewal. Furthermore, we show that BPTF potentiates the chromatin accessibility of key HSC ‘‘stemness’’ genes. These results
demonstrate an essential requirement of the chromatin remodeler BPTF and NURF for activation of ‘‘stemness’’ gene-expression
programs and proper function of adult HSCs.INTRODUCTION
Appropriate self-renewal and differentiation of adult stem
cells are essential for tissue homeostasis and are tightly
controlled by various cellular and molecular mechanisms,
including the dynamic regulation of chromatin structure
by ATP-dependent chromatin-remodeling complexes (Ka-
doch and Crabtree, 2015; Wang et al., 2007). These remod-
elers use energy produced fromATP hydrolysis to configure
nucleosomal positioning and modulate DNA accessibility.
Such a process ensures fidelity of crucial gene-expression
programs during developmental processes such as lineage
specification. In support of this pathway contributing to
cell fate determination, somatic mutation of chromatin re-
modeler genes is common in human disease, including
cancer (Kadoch and Crabtree, 2015; Wang et al., 2007).
Bromodomain PHD finger transcription factor (BPTF) is a
core and largest component of the conserved, multi-
subunit nucleosome remodeling factor (NURF) complex
(Landry et al., 2008; Ruthenburg et al., 2011). NURF
loosens condensed chromatin to promote DNA accessi-
bility and target gene activation (Ruthenburg et al., 2011;
Schwanbeck et al., 2004; Wysocka et al., 2006). While
global knockout of Bptf inmice leads to lethality on embry-
onic day 8.5, demonstrating its requirement for early
development (Landry et al., 2008), clinical studies reveal
loss-of-function mutation of BPTF in individuals withStem Cell R
This is an open access artisyndromic neurodevelopmental anomalies (Stankiewicz
et al., 2017). Furthermore, BPTF was recently shown to be
critical for themaintenance or differentiation ofmammary
gland stem cells (Frey et al., 2017), melanocytes (Dar et al.,
2016; Large et al., 2016), and Tcells (Landry et al., 2011;Wu
et al., 2016). BPTF contains two motifs in its C terminus, a
PHD finger and a bromodomain that bind to histone H3
lysine 4 trimethylation (H3K4me3) and histone acetyla-
tion, respectively (Chi et al., 2010; Ruthenburg et al.,
2011; Wysocka et al., 2006). Deposition of these two mod-
ifications occurs partly via the histone methyltransferase
MLL/KMT2A and associated histone acetyltransferases
(Dou et al., 2005).While previous works detail the essential
role for KMT2A in regulation of hematopoietic and
neuronal stem cells (Artinger et al., 2013; Jude et al.,
2007; Lim et al., 2009), the specific contributions of BPTF
remain undefined in this process.
Using knockout mice, we here show BPTF as a crucial
chromatin regulator of hematopoietic stem cells (HSCs).
Reconstitution assays demonstrate that Bptf-null HSCs ex-
hibited the decreased repopulating capacity, causing severe
hematopoietic defects. Our genomic profiling shows that
ablation of BPTF in hematopoietic stem/progenitor cells
(HSPCs) leads to decreased expression of an HSC-specific
gene-expression program, which includes a master tran-
scription factor (TF) regulatory node (Meis1, Pbx1, Mn1,
and Lmo2) known to be crucial for HSC self-renewal andeports j Vol. 10 j 675–683 j March 13, 2018 j ª 2018 The Author(s). 675




Figure 1. Maintenance of Adult HSPCs Including LT-HSC Requires BPTF
(A) Bptf expression in hematopoiesis (see also Figures S1A and S1B).
(B and C) Genotyping (B) and RT-PCR (C; n = 3 biological replicates) confirm deletion of the Bptf exon 2 in total bone marrow (BM) 1 week
after cre induction. w, wild-type; f, floxed; D, deleted (BptfcKO).
(D and E) FACS (D) and summary (E) of percentages of the LSK and LT-HSC cells in the BM, 4 weeks after cre induction in the BptfcKO (f/f; cre,
n = 5mice) or control littermates with Bptff/f (f/f) orMx1-cre (cre) alone (n = 4mice). Numbers in (D) indicate the percentage of gated cells.
Plots in (E) are mean ± SD, with statistical analysis defined by two-tailed Student’s t test: ns, not significant; *p < 0.05; **p < 0.01.function.We also find that BPTF potentiates the chromatin
accessibility of these HSC TF genes. Collectively, our
results support a vital requirement of the BPTF chromatin
remodeler for the maintenance of adult HSPCs and for
the activation of a gene transcription program essential
for HSC functions.RESULTS
Maintenance of Adult HSPCs, Including Long-Term
HSCs, Requires Bptf Expression
Using transcriptome datasets of hematopoiesis (Bock et al.,
2012; Seita et al., 2012), we found Bptf preferentially ex-
pressed in the primitive HSPC compartment (Figures 1A,
S1A, and S1B). To study the role of BPTF in HSPCs, we pro-
duced inducible knockout mice (Bptfflf;Mx1-cre) designed
to ablate Bptf from the bone marrow (BM) upon activation
of Mx1-cre by polyinosinic-polycytidylic acid (pIpC).
We verified efficient deletion (>95%) of Bptf in the BM676 Stem Cell Reports j Vol. 10 j 675–683 j March 13, 2018(i.e., BptfcKO) via genotyping and RT-PCR to confirm our
model (Figures 1B and 1C). While Mx1-cre is widely used
for achieving inducible gene deletion in HSPC, it is also
associated with pIpC-caused interferon activation and
cre-induced potential toxicity. To address these issues, we
produced littermate controls with Bptfflf or Mx1-cre alone
and subjected them to pIpC administration. By fluores-
cence-activated cell sorting (FACS) and 4 weeks after cre in-
duction, we observed a significantly reduced total number
of lineage/SCA-1+/c-KIT+ (LSK) cells and long-term (LT)-
HSCs (LSK/CD150+/CD48, Figure 1D) in the BMof BptfcKO
mice, relative to controls (Figures 1D and 1E). This result
shows a role for BPTF in the maintenance of primitive
HSPCs, including LT-HSCs, in adult mice.BPTF Sustains the Self-Renewal and Repopulating
Capacity of HSCs in a Cell-Autonomous Mechanism
Next, we sought to determine whether BPTF regulates
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Figure 2. BPTF Is Essential for the Maintenance and Reconstitution Function of HSCs in a Cell-Autonomous Manner
(A and B) Summary (A) and representative colony (B; scale bar, 1 mm) in colony-forming unit assays with 300 of the Bptff/f or BptfcKO
(f/f; cre) LSK cells sorted 7 days after cre induction (n = 3 independent experiments; *p < 0.05; **p < 0.01; see also Figure S1C).
(C) Outline of competitive reconstitution assay via BMT.
(D) Percentage of donor-derived CD45.2+ cells from BptfcKO (blue; n = 8 mice) and control mice, either Bptff/f (red; n = 8) or Bptf-/w
(green; n = 6), in peripheral blood of recipients at the indicated time points. Error bars denote SE.
(E) FACS of donor-derived CD45.2+ cells, either from Bptff/f or BptfcKO mice, in peripheral blood 5 weeks after cre induction.
(F–H) Summary (F and G; n = 2 mice at each time point) and FACS (H) of donor-derived CD45.2+ cells, either from control (Bptff/f) or BptfcKO
mice, in the BM LSK and LT-HSC populations 8 weeks after cre induction (see also Figure S1D).
(I and J) Percentage (I; n = 4 mice) and FACS (J) of donor-derived CD45.2+ cells from Bptff/f or BptfcKOmice in the indicated BM populations
8 weeks after cre induction (see also Figures S1E and S1F).colony-forming assay with sorted LSK populations, we
found that Bptf-ablated cells produced significantly fewer
and smaller colonies relative to control (Figures 2A and
2B). Similar results were seen in LSK cells with short hairpinRNA-mediated knockdownofBptf (Figure S1C).We also per-
formed competitive bonemarrow transplantation (BMT) to
test the reconstitution capacity of Bptf-null HSCs. Here,
total BM cells from CD45.2+, Bptff/f;Mx1-cre+ mice wereStem Cell Reports j Vol. 10 j 675–683 j March 13, 2018 677
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Figure 3. RNA-Seq Profiling Identifies a BPTF-Dependent Gene-Activation Program that Includes Several Key Master Regulators
of HSCs
(A) IGV view showing the RNA-seq profile of Bptf in the Bptff/f and BptfcKO (f/f; cre) LSK cells after pIpC treatment. For cross-sample
comparison, the scale of profile is normalized with total sequencing read counts.
(B) The MA plot of RNA-seq transcriptome profiles in the BptfcKO versus Bptff/f LSK cells after pIpC treatment. The x axis shows the average
gene expression (log2-transformed) in control and knockout samples, while the y axis shows the indicated fold change by log2 trans-
formation. Each dot represents a gene. The red and green colors mark genes that show significant differential expression, with a cutoff of
adjusted p value (padj) < 0.05 and absolute log2(fold change) > 0.43. An inserted table summarizes the total number of transcripts found
up- or downregulated in BptfcKO LSK cells relative to Bptff/f controls, with the indicated cutoff of fold change (FC) and padj (see also
Figure S2A and Table S1).
(C) GO analysis reveals the indicated gene pathway among the transcripts downregulated in BptfcKO LSK cells relative to Bptff/f controls
(see also Figures S2B and S2C).
(D) RNA-seq identifies genes downregulated (left; green) or upregulated (right; red) in BptfcKO LSK cells, relative to Bptff/f controls.
Base Mean denotes the average RNA-seq count.
(legend continued on next page)
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mixed at a 1:1 ratio with wild-type competitor cells from
CD45.1+ mice, then used as donor for BMT to lethally irra-
diated recipients (Figure 2C). Cells from Bptff/f or heterozy-
gous Bptff/w;Mx1-cre+ mice were used as control in BMT.
When we observed stable chimerism in all cohorts 8 weeks
after BMT (Figure 2D), we induced Bptf deletion and
observed a gradual decline in the contribution of the
Bptf-null donor cells to peripheral blood (Figures 2D and
2E). Meanwhile, the percentages of control donor cells
remained stable after pIpC injection, suggesting that one
Bptf allele is sufficient to sustain HSC function and hemato-
poiesis (Figures 2D and 2E).
We also examined the LSK and LT-HSC populations in re-
cipients in the reconstitution assay (Figure S1D), and found
a significantly decreased contribution of BptfcKO but not
control donor cells to these primitive compartments (Fig-
ures 2F and 2G). Eight weeks after cre induction, the pres-
ence of Bptf-ablated donors decreased to nearly undetect-
able levels in HSCs and differentiated cell compartments
in the BM or spleen (Figures 2H–2J, S1E, and S1F). Loss of
the BptfcKO HSCs may occur through failure to maintain
HSPCs’ cell identity, increased apoptosis, or their combina-
tion. We assessed LSK cells 3 weeks after cre induction and
did not detect a significant increase in apoptosis in BptfcKO
mice relative to control (Figures S1G and S1H). Together,
these results show a cell-autonomous role of BPTF in sus-
taining the repopulating function of HSCs.
BPTF Activates an HSC-Specific Gene-Expression
Program, Including a ‘‘Stemness’’ Regulatory Node
that Comprises Several Master Regulators of HSCs
To define the gene-regulatory role of BPTF inHSPCs, we per-
formed RNA sequencing (RNA-seq) to profile transcrip-
tomes of the LSK cells sorted from BptfcKO and Bptff/f mice
10 days after cre induction (Figure S2A). As expected, there
was a lack of RNA-seq reads mapped to the Bptf exon 2 in
BptfcKO cells due to cre-mediated deletion (Figure 3A). This
produced the out-of-frame unstable Bptf transcripts, with
reduced overall expression when compared with control
(Figure 3B, Bptf). BptfcKO and Bptff/f LSK cells expressed
comparable levels of cKit, an LSK marker (Figure 3B, cKit),
and comparison of their RNA-seq profiles identified 407
downregulated and 230 upregulated transcripts due to Bptf
ablation (with adjusted p < 0.05 and fold change > 1.5;
Figure 3B [inset] and Table S1). Gene ontology (GO) and
Ingenuity Pathway Analysis revealed the transcription regu-
lation and cell adhesion-related pathways among the most
downregulated ones upon BPTF loss (Figures 3C and 3D),(E–H) GSEA reveals enrichment of the indicated signature, either LSK ‘
ribosomal genes (H) in BptfcKO versus Bptff/f LSK cells after cre induc
(I) qRT-PCR using the BptfcKO versus Bptff/f LSK cells sorted on day 10
and normalized to b-actin and Bptff/f cells. *p < 0.05; **p < 0.01.including a TF regulatory node that consists of Meis1,
Pbx1, Mn1, and Lmo2 (Figure S2B). Previous studies show
these TFs as master regulators of HSC by establishing the
gene-regulatory circuits essential for HSC self-renewal and
identity (Heuser et al., 2011; Wang et al., 2005; Wilson
et al., 2010). Consistently, when we related our RNA-seq
data to the previously reported HSC gene sets by gene set
enrichment analysis (GSEA), we found that, relative to
BptfcKO, Bptff/f LSK cells are enriched with LSK signature
genes (Chambers et al., 2007; Krivtsov et al., 2006) and
those sustained by a crucial HSC regulator, KMT2A
(Artinger et al., 2013) (Figures 3E–3G). Also, the AP1 com-
plex TFs (e.g., Fos and Jun) showed decreased expression in
BptfcKO LSK cells (Figure 3D, left). GO and GSEA also found
the biosynthesis- and translation-related pathways among
the most upregulated ones in BptfcKO cells (Figures 3H and
S2C–S2E), a phenomenon similar to that reported in the
KMT2A-null HSPCs (Artinger et al., 2013). Themost upregu-
lated genes include many aminoacyl-tRNA synthetase and
solute carrier protein genes (Figure 3D, right). By RT-PCR,
we validated downregulation of Pbx1, Meis1, Mn1, and
Lmo2 upon Bptf loss in LSK cells, while expression of Myc,
cKit, and Cd34 was unchanged (Figure 3I). Thus, we identi-
fied a BPTF-dependent gene-expression program that
includes several master TFs of HSCs, which supports a role
of BPTF in defining HSCs’ cellular identity.
BPTF Potentiates DNA Accessibility at the HSC
‘‘Stemness’’ Genes
To test whether BPTF directly targets the ‘‘stemness’’ genes
identified by RNA-seq, we assessed BPTF binding by chro-
matin immunoprecipitation (ChIP). We used HPC-7 cells
because ChIP requires large cell numbers, which prevents
the use of primary HSPCs, and HPC-7 cells were previ-
ously used as an HSPC mimic to map the genomic bind-
ing of HSC regulators (Wilson et al., 2010). ChIP-
sequencing (ChIP-seq) analysis revealed high H3K4me3
at the promoters of ‘‘stemness’’ genes such as Meis1,
Pbx1, and Lmo2 (Figures 4A–4C and S3A, top panel),
providing a putative platform for BPTF binding. Unfortu-
nately, BPTF ChIP-seq failed due to inadequate pull-down
of DNA, but conventional ChIP-qPCR showed significant
binding of BPTF to the tested promoter loci at ‘‘stemness’’
genes, compared with the negative control (Figure 4D).
Because BPTF/NURF modulates nucleosomal positioning,
we also used the assay for transposase-accessible chro-
matin followed by sequencing (ATAC-seq) to measure
DNA accessibility in BptfcKO versus Bptff/f LSK cells after‘stemness’’ genes (E and F), a KMT2A-sustained gene network (G), or
tion (see also Figures S2D and S2E).
after cre induction. Data are mean ± SD (n = 3 biological replicates)
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Figure 4. BPTF Potentiates Chromatin Accessibility at HSC ‘‘Stemness’’ Genes
(A–C) ChIP-seq profiles of H3K4me3 and input at the indicated genes in HPC-7 cells, and their ATAC-seq profiles in Bptff/f versus BptfcKO
LSK cells 7 days after cre induction. For cross-sample comparison, the scales of profiles are normalized with total sequencing read counts
(see also Figure S3A).
(D) BPTF ChIP at the indicated gene promoter in HPC-7 cells. Fold of enrichment in signals, shown as mean ± SD (n = 3 biological
replicates), was normalized to input and to a control locus (Chr8_Int). *p < 0.05; **p < 0.01.
(E) Comparison of ATAC-seq data in BptfcKO versus Bptff/f LSK cells shows a significant reduction of ATAC-seq signals at the promoters of
genes showing downregulation due to BPTF loss, relative to genome background. Plotted at y axis are log2-transformed ratios of promoter-
associated ATAC-seq reads between two samples, either at all genes (left) or at the top 500 downregulated genes in BptfcKO LSK cells
(right), relative to Bptff/f control (see also Figures S3B and S3C).
(legend continued on next page)
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cre induction (Figure S3B). Upon Bptf ablation, we did not
see a dramatic change in global ATAC-seq signals (Fig-
ure S3C) but observed significantly reduced DNA accessi-
bility at the promoters of downregulated genes (Figure 4E)
such as Meis1, Pbx1, Fos, and Lmo2 (Figures 4A–4C and
S3A). We also observed decreased ATAC-seq signals at
putative distal or intragenic enhancers of these TF genes
(Figures 4A–4C and S3A). Together, these genomic data
support crucial roles of BPTF in potentiating DNA accessi-
bility and appropriate expression of key HSC TF genes.
Further work is needed to firmly define genomic binding
of BPTF in HSPCs.
Hematopoietic-Specific Loss of BPTF Leads to Bone
Marrow Failure, Anemia, and Leukopenia
Given the impaired function of BptfcKO HSCs, we predicted
that lineage-committed populations in BptfcKO mice would
be affected. Four weeks after Bptf deletion, the bones from
BptfcKOmice appeared pale and showed significant decrease
in the total BM cell number when compared with control
(Figure 4F). Moreover, we observed that the BptfcKO mice
possessed smaller spleens relative to control, which sug-
gests a defect in splenic B cell development (Figure 4G).
FACS of total splenic cells confirmed our observation,
with a significant reduction in the B220+ cells (Figure S4A).
Furthermore, complete blood counts revealed anemia,
leukopenia, and granulocytopenia in BptfcKO mice, pheno-
types that arise from the dysfunctional repopulation capac-
ity of HSCs (Figures 4H–4J and S4B–S4D). Thus, we show
Bptf to be essential for normal hematopoiesis.DISCUSSION
BPTF Plays an Essential Role in the Maintenance and
Functionality of HSCs
How adult stem cells sustain themselves remains as an
intriguing question. Using knockout and reconstitution
systems, we showed an essential requirement of BPTF for
maintaining the HSPC populations and their repopulating
capacity. Mechanistically, our transcriptome profiling re-
vealed a previously unappreciated, BPTF-dependent gene-
activation program, which includes a set of master TFs
known to be vital for HSC self-renewal (Meis1, Pbx1, Mn1,
and Lmo2), the AP1 complex, and the MLL/KMT2A signa-
ture genes. BPTF also sustains an open chromatin state at
target ‘‘stemness’’ genes. Thus, BPTF acts as a safeguard of
adult hematopoiesis, ensuring HSCs’ reconstitution func-(F and G) Total cell numbers in the femur (F) and the size of spleen
induction. *p < 0.05; **p < 0.01.
(H–J) Complete blood counts of peripheral blood collected from BptfcK
(H); RBC, red blood cells (I); and platelets (J) (see also Figure S4). *tion. In support, BPTF loss caused BM failure phenotypes
that are reminiscent of what was observed for KMT2A-
null HSCs (Artinger et al., 2013; Jude et al., 2007). BPTF ap-
pears to be more crucial for blood formation under stressed
conditions (e.g., reconstitution in irradiated mice) than in
the steady state, a phenomenon also described in a condi-
tional KMT2A-null model (McMahon et al., 2007). How-
ever, depth study is required to dissect the potentially over-
lapping and distinctive roles for BPTF and KMT2 in HSC
self-renewal and blood formation.BPTF Controls Vital Gene-Expression Programs to
Sustain Homeostasis of Multiple Cell Lineages
In related research, BPTF acts as a crucial regulator of mam-
mary gland and epidermal stem cells (Frey et al., 2017;
Mulder et al., 2012), melanocytes (Koludrovic et al.,
2015), and T cells (Landry et al., 2011; Wu et al., 2016).
Here, an intriguing question is how the general chromatin
regulator BPTF controls a defined yet distinct gene-expres-
sion program among different cell lineages. Presumably
these cells differ in patterns of histone modifications,
which can stabilize BPTF binding to genes essential for
lineage definition. Also, BPTF/NURF interacts with
DNA-binding factors such as CTCF (Qiu et al., 2015) and
c-MYC (Richart et al., 2016a). A multivalent interaction
of NURF to histonemodifications, TFs, and other recruiting
factors can act in concert to dictate distinct genomic target-
ing of BPTF/NURF.The Essential Function of BPTF inNormal Tissue Raises
a Concern on Targeting It in Cancer Therapy
Recently, the oncogenic role of BPTF was reported in mel-
anoma (Dar et al., 2015, 2016), pancreatic tumors, and
Burkitt’s lymphoma (Richart et al., 2016b), where BPTF
was shown to promote the gene program related to tumor
cell growth or survival such as c-MYC and BCL2. Bptf
carries an H3K4me3-binding PHD and an acetyl-histone-
binding bromodomain. Both motifs including PHD asso-
ciate with human disease (Baker et al., 2008; Gough
et al., 2014; Wang et al., 2009) and can be potentially
druggable (Arrowsmith et al., 2012). BPTF was proposed
as a drug target for cancer therapy (Richart et al.,
2016a). However, increasing evidence now shows a vital
requirement of BPTF for normal homeostasis of a range
of tissues. Such broad homeostatic function for Bptf re-
quires additional studies to address toxicity associated
with targeting this protein in cancer.(G) in Bptff/f (n = 3) versus BptfcKO (n = 4) mice 4 weeks after cre
O mice (n = 4) and Bptff/f littermates (n = 4): WBC, white blood cells
**p < 0.001.
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EXPERIMENTAL PROCEDURES
Details of additional procedures such as BMT, FACS, sorting,
ATAC-seq, and ChIP are provided in Supplemental Experimental
Procedures.Knockout Mice
CD45.2+ B/6 mice carrying the Bptff/f allele (stock #009367) or
Mx1-cre were purchased from the Jackson Laboratory and crossed
to produce Bptff/f;Mx1-cre mice and control littermates. To induce
Bptf knockout in the BM, we injected 2- to 3-month-old mice
with pIpC (Sigma) three times every other day. UNC-Chapel Hill
Institutional Animal Care andUse Committee approved all animal
experiments.RNA-Seq
RNA was extracted from sorted LSK cells with the picoRNA Kit
(Applied Biosystems) and the RNA-seq library was prepared with
Illumina kits according to the manufacturer’s protocol, followed
by deep sequencing.
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